Jump Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Jump Financial’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,074	Closed	-$294K	–	1643
2024 Q4	$294K	Sell	14,074 -20,867	-60%	-$448K	0.01%	1311
2024 Q3	$695K	Buy	+34,941	New	+$648K	0.01%	973
2024 Q1	–	Sell	-64,122	Closed	-$1.08M	–	1949
2023 Q4	$1.08M	Buy	64,122 +32,138	+100%	+$439K	0.03%	678
2023 Q3	$374K	Buy	31,984 +14,715	+85%	+$197K	0.01%	1179
2023 Q2	$232K	Sell	17,269 -139,453	-89%	-$2.01M	0.01%	1449
2023 Q1	$2.6M	Buy	156,722 +77,393	+98%	+$1.28M	0.11%	301
2022 Q4	$1.48M	Buy	79,329 +31,829	+67%	+$490K	0.08%	337
2022 Q3	$609K	Sell	47,500 -34,401	-42%	-$408K	0.02%	813
2022 Q2	$574K	Sell	81,901 -21,593	-21%	-$158K	0.02%	791
2022 Q1	$858K	Sell	103,494 -18,906	-15%	-$134K	0.04%	583
2021 Q4	$829K	Buy	+122,400	New	+$805K	0.05%	455
2021 Q3	–	Sell	-37,983	Closed	-$219K	–	1157
2021 Q2	$219K	Sell	37,983 -17,117	-31%	-$88.3K	0.02%	817
2021 Q1	$254K	Buy	+55,100	New	+$219K	0.02%	671
2020 Q4	–	Sell	-52,500	Closed	-$156K	–	979
2020 Q3	$156K	Buy	+52,500	New	+$205K	0.03%	660

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Jump Financial's CPRX Position: Q1 2025 in Review

Jump Financial sold out of Catalyst Pharmaceutical (CPRX) in Q1 2025, closing a stake of 14,074 shares — an estimated $294K sold.

Jump Financial first reported a position in CPRX in Q3 2020 and held it in 14 quarters. The position peaked at $2.6M in Q1 2023. 371 funds tracked by Wall St. Rank hold CPRX as of Q1 2025.

Jump Financial reported no remaining Catalyst Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Jump Financial sold 14,074 Catalyst Pharmaceutical shares in Q1 2025, an estimated $294K.
Jump Financial first reported a position in Catalyst Pharmaceutical in Q3 2020 and held it in 14 quarters.
Jump Financial's Catalyst Pharmaceutical position peaked at $2.6M in Q1 2023.
371 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.